WESTLAKE VILLAGE, Calif., Feb. 27, 2013 /PRNewswire/ -- Envy Medical Inc., maker of the breakthrough "facial miracle" treatments SilkPeel® and the Lumixyl® Topical Brightening System, announces the new Lumixyl® Topical Brightening Pads. Available nationwide in Spring 2013, you now can brighten and smooth skin with a facial pad that simplifies your beauty routine while perfecting your complexion.
Lumixyl Topical Brightening Pads are the newest addition to the Lumixyl Topical Brightening System of products. The pads pack the same strength of the Topical Brightening Creme, Lumixyl's flagship product that's gained a beauty cult following. The difference? "For the first time, the Lumixyl peptide has been infused into gently exfoliating woven pads along with hydrating hyaluronic acid and soothing aloe. It's ideal for the great number of people who have issues with dry skin while using acne medications, retinoids, or post-laser treatment," says Curtis Cluff, CEO of Envy Medical.
The Lumixyl line of products is clinically proven to brighten skin and visibly improve the appearance of mild to moderate hyperpigmentation in 8 weeks thanks to the superstar ingredient decapeptide-12, a revolutionary peptide technology developed by Stanford University researchers. Decapeptide-12 reduces the appearance of hyperpigmentationage spots, sun spots, uneven skin tone and photo damagewithout the typical side effects of other brighteners like irritation and redness. Plus, soothing antioxidants like licorice root also ease sensitive skin.
"The Lumixyl peptide technology has been an effective tool for treating hyperpigmentation in my practice, says Los Angeles dermatologist Rebecca Fitzgerald, MD. "The Topical Brightening Pads will be a very welcome addition in providing a more healthy, radiant skin tone for our patients."
Paraben-, fragrance- and alcohol-free, the product can be used on all skin types. Also applying these Brightening Pads between SilkPeel treatments will help maintain smoothness and brightness. For best results in addressing photo damage, improving skin texture and reducing melasma, use the Brightening Pads along with the full Lumixyl Topical Brightening System.
DebutingatThe American Academy of Dermatology's 71st Annual Meeting in Miami Beach, March 1-5, 2013, the Lumixyl Topical Brightening Pads will formally launch in June 2013, retailing for $59. They will be sold through dermatology, cosmetic surgery and medical spa physicians throughout the United States as well as on www.Lovelyskin.com, www.Skin-etc.com, www.Skinstore.com and www.Spalook.com.
For more information go to www.Lumixyl.com, or contact email@example.com.
ABOUT ENVY MEDICAL Envy Medical develops, markets and sells highly effective non-invasive skin rejuvenation therapies for patients suffering from either dermatologic or aesthetic conditions. The Company's lead products include SilkPeel®, a breakthrough device combining exfoliation with Dermalinfusion® for deeper tissue delivery of active ingredients and better patient outcomes. Envy is also the exclusive licensor of skin brightening peptides including Lumixyl, developed at Stanford University. The Lumixyl peptide is available in Envy's Lumixyl Topical Brightening System as well as in a topical solution for SilkPeel procedures, addressing hyperpigmentation and photodamage. More information can be found at www.envymedical.com.
SOURCE Envy Medical Inc.